Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir. [electronic resource]
Producer: 20140213Description: 902-11 p. digitalISSN:- 1527-3350
- Adult
- Antiviral Agents -- therapeutic use
- Carbamates
- Dose-Response Relationship, Drug
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Isoquinolines -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Pyrrolidines
- RNA, Viral -- genetics
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Sulfonamides -- therapeutic use
- Treatment Failure
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Nonstructural Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.